Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan

Affiliations

Editorial

Shingo Hatakeyama et al. Int J Urol. 2021 Aug.

. 2021 Aug;28(8):820.

doi: 10.1111/iju.14593. Epub 2021 May 19.

¹ Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

No abstract available

Comment on

Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Shiga M, Nagumo Y, Chihara I, Nitta S, Kojo K, Kimura T, Kandori S, Kojima T, Okuyama A, Higashi T, Nishiyama H. Shiga M, et al. Int J Urol. 2021 Aug;28(8):814-819. doi: 10.1111/iju.14583. Epub 2021 May 19. Int J Urol. 2021. PMID: 34013614

1. Roupret M, Babjuk M, Burger M et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur. Urol. 2021; 79: 62-79.
1. Honda Y, Nakamura Y, Teishima J et al. Clinical staging of upper urinary tract urothelial carcinoma for T staging: review and pictorial essay. Int. J. Urol. 2019; 26: 1024-32.
1. Shiga M, Nagumo Y, Chihara I et al. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: analysis of the Hospital-Based Cancer Registry data in Japan. Int. J. Urol. 2021; 28: 814-9.
1. Hamaya T, Hatakeyama S, Tanaka T et al. Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study. BJU Int. 2021; https://doi.org/10.1111/bju.15346.
1. Foerster B, Abufaraj M, Mari A et al. The performance of tumor size as risk stratification parameter in upper tract urothelial carcinoma (UTUC). Clin. Genitourin. Cancer 2020; https://doi.org/10.1016/j.clgc.2020.09.002.